Valuation Atossa Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 18:42:26 13/08/2026 BST			5-day change	1st Jan Change
2.510 ^USD	+6.81%		+3.31%	-71.75%

08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	202.6	66.92	110.3	118.8	76.21	20.24	-	-
Change	-	-66.97%	64.77%	7.71%	-35.83%	-73.45%	-	-
Enterprise Value (EV)	202.6	66.92	110.3	118.8	76.21	20.24	20.24	20.24
Change	-	-66.97%	64.77%	7.71%	-35.83%	-73.45%	0%	0%
P/E	-8.89x	-2.52x	-3.67x	-4.72x	-2.19x	-0.55x	-0.69x	-0.78x
PBR	1.47x	0.57x	1.22x	1.69x	1.92x	-	-	-
PEG	-	-0.2x	-0.3x	0.3x	-0.1x	-0.1x	0x	0.1x
Capitalization / Revenue	-	-	-	-	-	-	-	0.17x
EV / Revenue	-	-	-	-	-	-	-	0.17x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.54x	-0.51x	0.43x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.7	-3.15	-3.6	-3	-4.04	-4.26	-3.43	-3
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	118.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-20.52	-27.69	-31.38	-27.62	-37.14	-37.57	-39.36	47.46
Net income ¹	-20.61	-26.96	-30.09	-25.5	-34.77	-37.06	-39.36	-42
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	24.000	7.927	13.200	14.161	8.850	2.350	2.350	2.350
Nbr of stocks (in thousands)	8,442	8,442	8,354	8,387	8,611	8,611	-	-
Announcement Date	28/02/22	22/03/23	01/04/24	25/03/25	25/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ATOSSA THERAPEUTICS, INC.	-0.55x	-	-	-	20.24M
LONZA GROUP AG	33.25x	5.94x	17.67x	0.96%	48.72B
REVOLUTION MEDICINES, INC.	-21.3x	291.14x	-21.61x	-.--%	43.99B
BEONE MEDICINES AG	47.03x	5.44x	29.75x	-.--%	40.82B
IQVIA HOLDINGS INC.	31.13x	3.08x	13.29x	-.--%	39.79B
CELLTRION, INC.	30.74x	8.86x	22.27x	0.38%	32.7B
MEDPACE HOLDINGS, INC.	33.95x	5.56x	25.27x	-.--%	16.66B
EUROFINS SCIENTIFIC SE	23.2x	2.03x	8.81x	1.16%	13.95B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	76.09x	4.01x	15.56x	-.--%	13.58B
Average	28.17x	40.76x	13.88x	0.31%	27.8B
Weighted average by Cap.	27.05x	55.59x	12.54x	0.3%